文献速递颅颌面外科美容整形

神经阻滞用于儿童唇腭裂修复术后疼痛管理:系统综述与网状Meta分析

Nerve block for pain management in pediatric patients undergoing cleft lip and palate repair: A systematic review and network meta-analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-03-18

该系统综述与网状Meta分析纳入8项随机对照试验共550例患儿,评估神经阻滞对比其他方法在儿童唇腭裂修复术后疼痛控制中的效果。结果显示右美托咪定较对照提供更长的神经阻滞持续时间(增量值=6.33,95%CI 1.49:11.16),其实现更长神经阻滞的概率为89.98%,其次为芬太尼和哌替啶。结论支持神经阻滞尤其含右美托咪定在儿童唇腭裂修复术后疼痛管理中的有效性与安全性,辅助药物增强的神经阻滞可延长镇痛并减少对阿片类药物的依赖。

要点

  • 右美托咪定较对照延长神经阻滞持续时间,增量值=6.33(95%CI 1.49:11.16)。
  • 右美托咪定实现更长神经阻滞的概率为89.98%,其次为芬太尼和哌替啶。
  • 辅助药物增强的神经阻滞可延长镇痛并减少对阿片类药物的依赖。

核心结论

  • 本研究支持神经阻滞尤其含右美托咪定在儿童唇腭裂修复术后疼痛管理中的有效性与安全性。
  • 辅助药物增强的神经阻滞可延长镇痛并减少对阿片类药物的依赖。

研究设计与样本

  • 系统综述与网状Meta分析,遵循PRISMA指南,检索Embase、MEDLINE、Cochrane和SCOPUS数据库,无时间限制。
  • 共纳入8项随机对照试验,合计550例患者。

主要发现

  • 右美托咪定较对照提供更长的神经阻滞持续时间,增量值=6.33(95%CI 1.49:11.16)。
  • 右美托咪定实现更长神经阻滞的概率为89.98%,其次为芬太尼和哌替啶。

关键数值与推荐

  • 右美托咪定对比对照的神经阻滞持续时间增量值=6.33(95%CI 1.49:11.16)。
  • 右美托咪定实现更长神经阻滞的概率为89.98%。

临床怎么用

  • 原文结论支持神经阻滞尤其含右美托咪定用于儿童唇腭裂修复术后疼痛管理,辅助药物增强的神经阻滞可延长镇痛并减少对阿片类药物的依赖。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cleft lip and palate, a common congenital anomaly, occurs in approximately 1 in every 1000-1500 births. Effective postoperative pain management in pediatric patients undergoing repair for cleft lip and palate remains a challenge. Therefore, this systematic review and network meta-analysis aimed to assess the effectiveness of nerve block in controlling postoperative pain compared to other methods in pediatric patients who underwent cleft lip and palate repair. METHODS: This review adhered to the preferred reporting items for systematic reviews and meta-analysis guidelines. A comprehensive search was conducted across multiple databases, including Embase, MEDLINE, Cochrane, and SCOPUS, without time frame limitation. RESULTS: A total of 8 randomized controlled trials comprising 550 patients were included. The findings of the study indicate that dexmedetomidine provided longer duration of nerve block (incremental value = 6.33, CI 95%, 1.49: 11.16) compared to the control. Thus, the probability of dexmedetomidine achieving longer nerve block is 89.98%. This was followed by fentanyl and pethidine. CONCLUSION: This study supports the efficacy and safety of nerve blocks, particularly with dexmedetomidine, for postoperative pain management in pediatric cleft lip and palate repair. Adjuvant-enhanced nerve blocks offer extended pain relief and reduce the reliance on opioids.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Alhindi N, Nukaly H, Abdulrahman L, et al. Nerve block for pain management in pediatric patients undergoing cleft lip and palate repair: A systematic review and network meta-analysis. J Plast Reconstr Aesthet Surg. 2025. PMID: 40203658. doi:10.1016/j.bjps.2025.03.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。